Alison Armour MBChB, BSc, MSc, MD, MRCP, FRCR

Dr. Alison Amour joined the company as Chief Medical Officer in August 2015. Prior to joining Endocyte, led the global strategic development of small molecule receptor tyrosine kinase therapy in breast and lung cancer at Novartis, GSK, and AZ. Before joining industry in 2004, Dr. Amour established herself as a thought leader in medical and radiation oncology and has doctorate on the specific targeting of tumors with radionuclide therapy. She practiced for many years at the Beatson Oncology Center in Glasgow. Dr. Amour graduated with a B.Sc. in biochemistry and M.B.,Ch.B. medical degree from Glasgow University Scotland in 1987. She practiced in acute hospital medicine for several years before specializing in both radiation and medical oncology. She holds an MSc in clinical oncology and FRCR at the Royal College of Radiologists London, UK. She was recently awarded the prestigious FRCP award for contribution to the field on medicine and oncology from the Royal College of Physicians in London. She lives in Indianapolis with her husband and daughter and is a keen portrait artist.